{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T10:37:57Z","timestamp":1786358277031,"version":"build-2736575974"},"reference-count":20,"publisher":"BMJ","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Heart"],"published-print":{"date-parts":[[2000,6,1]]},"DOI":"10.1136\/heart.83.6.721","type":"journal-article","created":{"date-parts":[[2002,7,27]],"date-time":"2002-07-27T06:33:18Z","timestamp":1027751598000},"page":"721-725","source":"Crossref","is-referenced-by-count":106,"title":["Worldwide perspective of valve disease"],"prefix":"10.1136","volume":"83","author":[{"given":"Jordi","family":"Soler-Soler","sequence":"first","affiliation":[{"name":"Servicio de Cardiolog\u00eda, Hospital General Universitari Vall d'Hebron. Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrique","family":"Galve","sequence":"additional","affiliation":[{"name":"Servicio de Cardiolog\u00eda, Hospital General Universitari Vall d'Hebron. Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2000,6,1]]},"reference":[{"key":"2025101711192979000_83.6.721.1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198702193160801"},{"key":"2025101711192979000_83.6.721.2","unstructured":"Narula J Virmani R Reddy KS Tandon R , eds (1999) . Rheumatic fever. Armed Forces Institute of Pathology (American Registry of Pathology, Washington) This book is a comprehensive multidisciplinary review of the state of the art of rheumatic fever at the present time. The monograph comprises aspects such as history, epidemiology, microbiology of group A streptococci, clinical manifestations, the problem of the resurgence of rheumatic fever, treatment, and prevention (including the progress on the vaccine development)."},{"key":"2025101711192979000_83.6.721.3","unstructured":"World Health Organization (1988) Rheumatic fever and rheumatic heart disease. WHO Technical Report Series no. 764. (WHO, Geneva) ."},{"key":"2025101711192979000_83.6.721.4","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(05)81146-1"},{"key":"2025101711192979000_83.6.721.5","doi-asserted-by":"publisher","DOI":"10.1016\/S0891-5520(05)70052-0"},{"key":"2025101711192979000_83.6.721.6","doi-asserted-by":"publisher","DOI":"10.1016\/S0025-6196(12)61880-1"},{"key":"2025101711192979000_83.6.721.7","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(96)00563-3"},{"key":"2025101711192979000_83.6.721.8","doi-asserted-by":"publisher","DOI":"10.1136\/hrt.78.5.472"},{"key":"2025101711192979000_83.6.721.9","doi-asserted-by":"publisher","DOI":"10.1136\/hrt.78.5.475"},{"key":"2025101711192979000_83.6.721.10","doi-asserted-by":"publisher","DOI":"10.1016\/S0146-2806(97)80013-8"},{"key":"2025101711192979000_83.6.721.11","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.158.18.2043"},{"key":"2025101711192979000_83.6.721.12","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1016\/0735-1097(89)90277-5","article-title":"Cardiac complications in acquired immunodeficiency syndrome (AIDS): a review.","volume":"13","author":"Acierno","year":"1989","journal-title":"J Am Coll Cardiol"},{"key":"2025101711192979000_83.6.721.13","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1002\/clc.4960210704","article-title":"Cardiac involvement in acquired immunodeficiency syndrome\u2014a review to push action. The committee for the study of cardiac involvement in AIDS.","volume":"21","author":"Milei","year":"1998","journal-title":"Clin Cardiol"},{"key":"2025101711192979000_83.6.721.14","doi-asserted-by":"crossref","first-page":"50","DOI":"10.7326\/0003-4819-117-1-50","article-title":"Valve disease associated with ergot alkaloid use. Echocardiographic and pathologic correlations.","volume":"117","author":"Redfield","year":"1992","journal-title":"Ann Intern Med"},{"key":"2025101711192979000_83.6.721.15","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199708283370901"},{"key":"2025101711192979000_83.6.721.16","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199809103391101"},{"key":"2025101711192979000_83.6.721.17","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199809103391102"},{"key":"2025101711192979000_83.6.721.18","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199809103391103"},{"key":"2025101711192979000_83.6.721.19","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1161\/01.CIR.84.2.920","article-title":"Antiphospholipid antibodies and the heart. Lessons and pitfalls for the cardiologist.","volume":"84","author":"Asherson","year":"1991","journal-title":"Circulation"},{"key":"2025101711192979000_83.6.721.20","doi-asserted-by":"crossref","first-page":"293","DOI":"10.7326\/0003-4819-116-4-293","article-title":"Valvular heart disease in the primary antiphospholipid syndrome.","volume":"116","author":"Galve","year":"1992","journal-title":"Ann Intern Med"}],"container-title":["Heart"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/heart.83.6.721","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T18:19:37Z","timestamp":1760725177000},"score":1,"resource":{"primary":{"URL":"https:\/\/heart.bmj.com\/lookup\/doi\/10.1136\/heart.83.6.721"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,6,1]]},"references-count":20,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2000,6,1]]},"published-print":{"date-parts":[[2000,6,1]]}},"alternative-id":["10.1136\/heart.83.6.721"],"URL":"https:\/\/doi.org\/10.1136\/heart.83.6.721","relation":{},"ISSN":["1355-6037","1468-201X"],"issn-type":[{"value":"1355-6037","type":"print"},{"value":"1468-201X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,6,1]]}}}